fashion -WSS

fashion

author：focus 2025-09-30 18:17:42 - browse：4977

Thomas Massie -- health policy coverage from STAT — Rep. Thomas Massie (R-Ky.) Kevin Dietsch/Getty Images

WASHINGTON — House lawmakers late Tuesday voted to attach a U.S. ban on controversial infectious disease research to legislation that could ultimately fund federal health agencies like the National Institutes of Health.

The bill would bar any federal agencies from funding so-called gain-of-function research, which involves altering a pathogen to study its spread, potentially making it more transmissible or severe in the process.

The spending bill already included a restriction on funding this research in any country determined to be a “foreign adversary,” including China. Scientists at the Wuhan Institute of Virology studied gain-of-function in some viruses, fueling theories that the Covid-19 pathogen was a lab leak. Those theories have never definitively been proven.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Attacks on the drug industry will lead to fewer breakthroughs

focus

WSS

NIH study of ME/CFS points to clear biological hallmarks

The drug industry sees a key ally in the Senate prevail

A solution to the after

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

He's a Nobel laureate. Critics say he was misleading on Covid

entertainment

fashion

leisure time

Guidelines to prevent youth baseball injuries need more muscle

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

Wildfire smoke exposes gaps in outdoor worker protections

He's a Nobel laureate. Critics say he was misleading on Covid

After affirmative action ruling, medical educators look to 'holistic review'

'Ancient DNA,' 23andMe reveal African American ancestries

Alkermes shareholders re

Medicare inequities exacerbate Puerto Rico’s health disparities

In Memoriam: Notable people who died in 2023

The drug industry sees a key ally in the Senate prevail

entertainment

Humana, CVS hope to turn members into patients at clinics

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

Influencer to be charged after chaos erupts in New York City's Union Square

NIH study of ME/CFS points to clear biological hallmarks

R1 RCM gets $5.8 billion buyout offer from private equity firm

Obesity drugs seen as possible treatment for liver disease MASH

focus

focus

focus

entertainment